Literature DB >> 20490722

Rare pediatric non-hodgkin lymphoma.

Bhuvana A Setty1, Amanda M Termuhlen.   

Abstract

Of the cases of non-Hodgkin lymphoma (NHL) diagnosed in children and adolescents, 10% comprise a diverse mixture of unusual B-cell or T-cell disease, some types of which are more commonly seen in adults. Understanding of these rare types of NHL comes from small pediatric case series or the adult literature. Some rare pediatric NHL is similar to adult NHL, but other types have different molecular and cytogenetic characteristics. It is important to improve understanding and treatment of these rare pediatric NHLs through international collaborative efforts.

Entities:  

Mesh:

Year:  2010        PMID: 20490722     DOI: 10.1007/s11899-010-0055-9

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  52 in total

1.  Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma.

Authors:  Antonio Cozzio; Werner Kempf; Regula Schmid-Meyer; Michel Gilliet; Sonja Michaelis; Leo Schärer; Günter Burg; Reinhard Dummer
Journal:  Leuk Lymphoma       Date:  2006-05

2.  Primary mediastinal (thymic) large B-cell lymphoma with a der(14)t(8;14)(q24;q32) and a translocation of MYC to the derivative chromosome 14 with a deleted IgH locus.

Authors:  Eva Stejskalova; Marie Jarosova; Edita Kabickova; Vratislav Smelhaus; Marcela Mrhalova; Roman Kodet
Journal:  Cancer Genet Cytogenet       Date:  2006-10-15

Review 3.  Primary mediastinal B-cell lymphoma.

Authors:  Peter W M Johnson; Andrew J Davies
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

4.  Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.

Authors:  Shimareet Kumar; Stefania Pittaluga; Mark Raffeld; Michael Guerrera; Nita L Seibel; Elaine S Jaffe
Journal:  Pediatr Dev Pathol       Date:  2005-02-23

5.  Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial.

Authors:  Ilske Oschlies; Wolfram Klapper; Martin Zimmermann; Matthias Krams; Hans-Heinrich Wacker; Birgit Burkhardt; Lana Harder; Reiner Siebert; Alfred Reiter; Reza Parwaresch
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

6.  Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

Authors:  Catherine Patte; Anne Auperin; Mary Gerrard; Jean Michon; Ross Pinkerton; Richard Sposto; Claire Weston; Martine Raphael; Sherrie L Perkins; Keith McCarthy; Mitchell S Cairo
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

7.  Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.

Authors:  K Kerl; C Prins; J H Saurat; L E French
Journal:  Br J Dermatol       Date:  2006-12       Impact factor: 9.302

8.  MALT lymphoma in children: a report from the NHL-BFM Study Group.

Authors:  Alexander Claviez; Ulrike Meyer; Christoph Dominick; James F Beck; Manfred Rister; Markus Tiemann
Journal:  Pediatr Blood Cancer       Date:  2006-08       Impact factor: 3.167

9.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

10.  Clinicopathological features and T-cell receptor gene rearrangement findings of mycosis fungoides in patients younger than age 20 years.

Authors:  Sang-Tae Kim; Hyung-Jun Sim; Young-Seung Jeon; Jin-Woo Lee; Hyo-Jin Roh; Soo-Young Choi; Yeong-Jin Kim; Kee-Suck Suh
Journal:  J Dermatol       Date:  2009-07       Impact factor: 4.005

View more
  1 in total

1.  Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt.

Authors:  Laila M Sherief; Usama R Elsafy; Elhamy R Abdelkhalek; Naglaa M Kamal; Doaa M Youssef; Rabab Elbehedy
Journal:  Mol Clin Oncol       Date:  2014-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.